Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Veoza
Veoza is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
